These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33792049)

  • 41. Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease.
    Rehan S; Giroud N; Al-Yawer F; Wittich W; Phillips N
    J Alzheimers Dis; 2021; 83(3):1125-1148. PubMed ID: 34397410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered dynamic amplitude of low-frequency fluctuation in individuals at high risk for Alzheimer's disease.
    Zhu QQ; Tian S; Zhang L; Ding HY; Gao YX; Tang Y; Yang X; Zhu Y; Qi M
    Eur J Neurosci; 2024 May; 59(9):2391-2402. PubMed ID: 38314647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Right hemisphere pitch-mismatch negativity reduction in patients with major depression: An MEG study.
    Hirakawa N; Hirano Y; Nakamura I; Hirano S; Sato J; Oribe N; Ueno T; Kanba S; Onitsuka T
    J Affect Disord; 2017 Jun; 215():225-229. PubMed ID: 28340449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disrupted morphological brain network organization in subjective cognitive decline and mild cognitive impairment.
    Chen Y; Liang L; Wei Y; Liu Y; Li X; Zhang Z; Li L; Deng D
    Brain Imaging Behav; 2024 Apr; 18(2):387-395. PubMed ID: 38147273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional-structural degeneration in dorsal and ventral attention systems for Alzheimer's disease, amnestic mild cognitive impairment.
    Qian S; Zhang Z; Li B; Sun G
    Brain Imaging Behav; 2015 Dec; 9(4):790-800. PubMed ID: 25452158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of regional gray matter volume abnormalities in Alzheimer׳s disease and late life depression with hippocampal atrophy using VSRAD analysis: a voxel-based morphometry study.
    Shimoda K; Kimura M; Yokota M; Okubo Y
    Psychiatry Res; 2015 Apr; 232(1):71-5. PubMed ID: 25773003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct Cognitive and Brain Morphological Features in Healthy Subjects Unaware of Informant-Reported Cognitive Decline.
    Sánchez-Benavides G; Grau-Rivera O; Cacciaglia R; Suárez-Calvet M; Falcon C; Minguillon C; Gramunt N; Sala-Vila A; Gispert JD; Molinuevo JL
    J Alzheimers Dis; 2018; 65(1):181-191. PubMed ID: 30010134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships.
    Manca R; Venneri A
    Curr Alzheimer Res; 2020; 17(12):1102-1114. PubMed ID: 33459235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    Kim REY; Lee M; Kang DW; Wang SM; Kim D; Lim HK
    J Alzheimers Dis; 2024; 97(1):259-271. PubMed ID: 38143346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subjective cognitive decline-related worries modulate the relationship between global amyloid load and gray matter volume in preclinical Alzheimer's disease.
    Wang X; Wang M; Wang X; Zhou F; Jiang J; Liu H; Han Y
    Brain Imaging Behav; 2022 Jun; 16(3):1088-1097. PubMed ID: 34743296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to Alzheimer's disease in mild cognitive impairment.
    Sohn BK; Yi D; Seo EH; Choe YM; Kim JW; Kim SG; Choi HJ; Byun MS; Jhoo JH; Woo JI; Lee DY
    J Korean Med Sci; 2015 Jun; 30(6):779-87. PubMed ID: 26028932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
    Morgen K; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
    J Alzheimers Dis; 2013; 37(2):389-401. PubMed ID: 23948881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.
    Okonkwo OC; Xu G; Dowling NM; Bendlin BB; Larue A; Hermann BP; Koscik R; Jonaitis E; Rowley HA; Carlsson CM; Asthana S; Sager MA; Johnson SC
    Neurology; 2012 May; 78(22):1769-76. PubMed ID: 22592366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
    Huang X; Zhang Q; Hu PH; Zhong YL; Zhang Y; Wei R; Xu TT; Shao Y;
    Med Sci Monit; 2016 Apr; 22():1115-23. PubMed ID: 27045330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.